TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19055280

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Changqiang (GV 1) and Chengshan (BL 57) with sparse‐dense wave, frequency 2/100 Hz for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Medication group with oral Tramadol and rectal Mayinglong Shexiang Zhichuang Suppository for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison between electroacupuncture and medication groups
Number of subjects: 120
Study: 15779040

Group type: EXPERIMENTAL
Intervention: Condition F-NF (fat before nonfat)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Condition NF-F (nonfat before fat)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Condition F-NF
Number of subjects: 8

Group type: COMPARATOR
Intervention: Condition NF-F
Number of subjects: 8
Study: 14988669

Group type: EXPERIMENTAL
Intervention: a-interferon (a-IFN)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: pegylated interferon (considered for future treatment)
Number of subjects: 154
Study: 12476366

Group type: EXPERIMENTAL
Intervention: Graded compression leg bandages (LB)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intermittent electric calf muscle stimulation (IECS)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study: 10519475

Group type: EXPERIMENTAL
Intervention: Aerobic training for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (athletes/runners)
Number of subjects: 0
Study: 7747681

Group type: EXPERIMENTAL
Intervention: Early responders (requested medical assistance < 60 minutes after symptom onset)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Early responders
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Unmarried patients
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Patients experiencing symptoms at work
Number of subjects: 501
Study: 2153435

Group type: EXPERIMENTAL
Intervention: BTOC regimen
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: VP‐16/CDDP regimen
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: BTOC good risk patients
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: BTOC poor risk patients
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: VP‐16/CDDP good risk patients
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: VP‐16/CDDP poor risk patients
Number of subjects: 103

Group type: COMPARATOR
Intervention: VP‐16/CDDP vs BTOC for good risk patients
Number of subjects: 103
Study: 6273009

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31542082

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg per week starting from the first day after menstruation
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 188
Study: 28316003

Group type: EXPERIMENTAL
Intervention: Gammaplex 10%
Number of subjects: 48

Group type: COMPARATOR
Intervention: Gammaplex 5%
Number of subjects: 48
Study: 26417701

Group type: EXPERIMENTAL
Intervention: Real-time CPR visual feedback during cardiac arrest
Number of subjects: 1605

Group type: EXPERIMENTAL
Intervention: Just-in-Time CPR training
Number of subjects: 1605

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1605
Study: 24600231

Group type: EXPERIMENTAL
Intervention: Pantethine (600 mg/day from weeks 1 to 8 and 900 mg/day from weeks 9 to 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: COMPARATOR
Intervention: Pantethine and Placebo
Number of subjects: 32
Study: 22533799

Group type: EXPERIMENTAL
Intervention: Gum-chewing group (chewing xylitol-containing gum twice a day for 15 min; n = 95)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (no gum; n = 91)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Gum-chewing group
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 186
Study: 19866350

Group type: EXPERIMENTAL
Intervention: Bi‐peak
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bi‐dslope
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bi‐on
Number of subjects: 14
Study: 17697903

Group type: EXPERIMENTAL
Intervention: Extended-release metformin (MER) plus sulfonylurea (glyburide)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Sulfonylurea monotherapy
Number of subjects: 741
Study: 15064265

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg
Number of subjects: 459

Group type: COMPARATOR
Intervention: Tramadol 100 mg
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 11379168

Group type: EXPERIMENTAL
Intervention: Cooling intervention (decreasing temperature by 3 degrees C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 9506323

Group type: EXPERIMENTAL
Intervention: Withdrawal from digoxin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continued use of digoxin
Number of subjects: 0
Study: 8039909

Group type: EXPERIMENTAL
Intervention: 22, 11, or 5.5 micrograms of the conjugated A‐C vaccine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Approved meningococcal vaccine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline injections
Number of subjects: 50
Study: 2525975

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study: 29326331

Group type: EXPERIMENTAL
Intervention: Low-flow oxygen therapy (LFO2) for 2 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of VRT and chemosensitivity in logistic regression model
Number of subjects: 20
Study: 27190087

Group type: EXPERIMENTAL
Intervention: Linagliptin plus pioglitazone 15 mg
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Linagliptin plus pioglitazone 30 mg
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Linagliptin plus pioglitazone 45 mg
Number of subjects: 936

Group type: COMPARATOR
Intervention: Linagliptin monotherapy
Number of subjects: 936

Group type: COMPARATOR
Intervention: Pioglitazone monotherapy
Number of subjects: 936
Study: 23790011

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/day
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Rasagiline 2 mg/day
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1105
Study: 22409999

Group type: EXPERIMENTAL
Intervention: Intravenous insulin administration to keep blood glucose between 6 and 8 mmol/l during surgery (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group received insulin if blood glucose >14 mmol/l (n = 8)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous insulin administration (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 8)
Number of subjects: 20
Study: 20959577

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil capsules (800 mg/d of DHA)
Number of subjects: 2399

Group type: COMPARATOR
Intervention: Vegetable oil capsules without DHA (control)
Number of subjects: 2399
Study: 18954193

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation
Number of subjects: 139
Study: 16760246

Group type: EXPERIMENTAL
Intervention: Lay health worker outreach program
Number of subjects: 1005
Study: 16312927

Group type: EXPERIMENTAL
Intervention: Zhuang medicine medicated thread moxibustion
Number of subjects: 72

Group type: COMPARATOR
Intervention: Acupuncture-moxibustion (control)
Number of subjects: 72
Study: 10702451

Group type: EXPERIMENTAL
Intervention: 0.75% levobupivacaine (20 mL, 150 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: 0.75% racemic bupivacaine
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 0.75% levobupivacaine
Number of subjects: 56
Study: 9087976

Group type: EXPERIMENTAL
Intervention: Selegiline and alpha-tocopherol treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not receiving selegiline and alpha-tocopherol)
Number of subjects: 0
Study: 8403805

Group type: EXPERIMENTAL
Intervention: Potassium channel opener pinacidil
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Potassium channel blocker glibenclamide
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intravenous glucose loading
Number of subjects: 5
Study: 3512068

Group type: EXPERIMENTAL
Intervention: CCTV (telepsychiatry)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Face-to-face interviews (control)
Number of subjects: 0
Study: 3288525

Group type: EXPERIMENTAL
Intervention: Single intravenous dose of clavulanate‐potentiated amoxycillin (1200 mg) 2 hours before surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous cefotaxime (2 g each) in three doses during surgery, and 6 and 12 hours after surgery
Number of subjects: 100
Study: 31860360

Group type: EXPERIMENTAL
Intervention: Uncoached feigning
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Coached feigning
Number of subjects: 114

Group type: COMPARATOR
Intervention: Honest nonclinical
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Negative Impression Management (NIM) scale
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Malingering Index
Number of subjects: 114
Study: 31486724

Group type: EXPERIMENTAL
Intervention: Tech-supported home-based palliative care (HBPC) model with video consultation
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Standard home-based palliative care (HBPC) model with routine home visits by nurses and prescribing clinicians
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Tech-supported home-based palliative care (HBPC) model
Number of subjects: 10000
Study: 28751300

Group type: EXPERIMENTAL
Intervention: 10-week Internet-based guided self-help program with weekly therapist support via encrypted email
Number of subjects: 58

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 58
Study: 25979219

Group type: EXPERIMENTAL
Intervention: Transperitoneal approach
Number of subjects: 38

Group type: COMPARATOR
Intervention: Retroperitoneal approach
Number of subjects: 38
Study: 23052541

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg of 20% mannitol 150 min after the initiation of pneumoperitoneum
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% normal saline (control group)
Number of subjects: 40
Study: 22187187

Group type: EXPERIMENTAL
Intervention: Autologous platelet lysate
Number of subjects: 2

Group type: COMPARATOR
Intervention: Wait and see strategy
Number of subjects: 2
Study: 19029316

Group type: EXPERIMENTAL
Intervention: Posaconazole (400 mg twice daily)
Number of subjects: 25
Study: 16436790

Group type: EXPERIMENTAL
Intervention: Triage nurses applying the Ottawa Ankle Rules (OAR) for ordering roentgenograms before physician evaluation.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard departmental care (control).
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Triage nurses applying the OAR.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Patient satisfaction ratings.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Willingness to return for future care (WOR).
Number of subjects: 130
Study: 11986440

Group type: EXPERIMENTAL
Intervention: Informed consent conferences (ICCs) including the child-patient
Number of subjects: 14
Study: 10647358

Group type: EXPERIMENTAL
Intervention: SIGN guideline plus a formal training programme
Number of subjects: 2700000

Group type: COMPARATOR
Intervention: SIGN guidelines alone
Number of subjects: 2700000
Study: 7669307

Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration with 40 ml of bupivacaine 0.5% (pH 6.9) 15 minutes prior to incision
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Wound infiltration with bupivacaine at the end of surgery
Number of subjects: 56

Group type: COMPARATOR
Intervention: No local anesthetic infiltration (control group)
Number of subjects: 56
Study: 2073336

Group type: EXPERIMENTAL
Intervention: PEG‐SOD 500 units/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PEG‐SOD 1000 units/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not treated)
Number of subjects: 12
Study: 7031014

Group type: EXPERIMENTAL
Intervention: Halsted mastectomy
Number of subjects: 701

Group type: COMPARATOR
Intervention: Quadrantectomy
Number of subjects: 701
Study: 29794530

Group type: EXPERIMENTAL
Intervention: Active somatosensory stimulation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham somatosensory stimulation
Number of subjects: 55
Study: 28678940

Group type: EXPERIMENTAL
Intervention: Healthy eating intervention (six counseling sessions on healthy feeding during the child's first year of life)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 320
Study: 26289588

Group type: EXPERIMENTAL
Intervention: APF530 500 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: palonosetron 0.25 mg
Number of subjects: 0
Study: 24211000

Group type: EXPERIMENTAL
Intervention: Propofol-based patient-controlled sedation (PCS), 15mg bolus in 9 s
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo-based patient-controlled sedation (PCS), bolus of 1.5mL of a 20% lipid emulsion in 9 s
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo-based patient-controlled sedation (PCS)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Propofol-based patient-controlled sedation (PCS)
Number of subjects: 61
Study: 21168853

Group type: EXPERIMENTAL
Intervention: Fluconazole prophylaxis
Number of subjects: 38
Study: 18433946

Group type: EXPERIMENTAL
Intervention: HIV-1 immunogen
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 16968847

Group type: EXPERIMENTAL
Intervention: Wait-and-see prescription (WASP)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard prescription (SP)
Number of subjects: 283
Study: 14513232

Group type: EXPERIMENTAL
Intervention: Gemcitabine/cisplatin (GC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: MVAC
Number of subjects: 70
Study: 11320561

Group type: EXPERIMENTAL
Intervention: HLA B-18 frequency in patients with sarcoidosis
Number of subjects: 88

Group type: COMPARATOR
Intervention: HLA-DR1 presence in stage IV patients
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: HLA-A class I frequency
Number of subjects: 88
Study: 8776948

Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Compressed air nebulizer
Number of subjects: 0
Study: 1513609

Group type: EXPERIMENTAL
Intervention: Loracarbef (15 mg/kg/day in two divided doses)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Cefaclor (20 mg/kg/day in three divided doses)
Number of subjects: 214
Study: 6402915

Group type: EXPERIMENTAL
Intervention: Drip coffee
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instant coffee
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double strength instant coffee
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coffee consumed 1 hour before a meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coffee consumed 1 hour after a meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coffee with NaFeEDTA
Number of subjects: 0
Study: 30732198

Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT) application to the quadriceps and gastrocnemius muscles
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study: 29357912

Group type: EXPERIMENTAL
Intervention: eRegistry's interactive checklists and clinical decision support
Number of subjects: 7200

Group type: COMPARATOR
Intervention: Existing paper-based records
Number of subjects: 7200
Study: 27605494

Group type: EXPERIMENTAL
Intervention: Intervention Group (n = 30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control Group (n = 29)
Number of subjects: 59
Study: 25203150

Group type: EXPERIMENTAL
Intervention: Low-GI staple diet
Number of subjects: 140

Group type: COMPARATOR
Intervention: Normal diabetic diet control
Number of subjects: 140
Study: 24060022

Group type: EXPERIMENTAL
Intervention: Cemented HA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cementless HA
Number of subjects: 60
Study: 20836608

Group type: EXPERIMENTAL
Intervention: Implementation intention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-efficacy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 0
Study: 18753749

Group type: EXPERIMENTAL
Intervention: Restorations without leakage (L-) with fluoride dentifrice (FD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Restorations with leakage (L+)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Restorations with composite resin (CR) under non-fluoride dentifrice (NF)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Restorations with resin-modified glass ionomer cement (GI)
Number of subjects: 14
Study: 16054266

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 753

Group type: COMPARATOR
Intervention: Human soluble insulin
Number of subjects: 753
Study: 12492754

Group type: EXPERIMENTAL
Intervention: Motivational intervention (treatment as usual plus a one-session brief motivational intervention)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Motivational intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control (treatment as usual)
Number of subjects: 151
Study: 11345028

Group type: EXPERIMENTAL
Intervention: 50 mg of Ukrain
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 100 mg of Ukrain
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no Ukrain treatment)
Number of subjects: 75
Study: 8940324

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (0.7 g/kg) in women on ERT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo in women on ERT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alcohol ingestion (0.7 g/kg) in control women not on ERT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo in control women not on ERT
Number of subjects: 24
Study: 1286442

Group type: EXPERIMENTAL
Intervention: Telephone survey
Number of subjects: 60

Group type: COMPARATOR
Intervention: Site visit (gold standard)
Number of subjects: 60
Study: 2864936

Group type: EXPERIMENTAL
Intervention: Etilefrine pivalate (K 30 052, Ep)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etilefrine
Number of subjects: 0
Study: 30520271

Group type: EXPERIMENTAL
Intervention: Implementation intention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Typical instruction
Number of subjects: 38
Study: 30239207

Group type: EXPERIMENTAL
Intervention: Method to search for patterns and groupings of patterns in protein sequences
Number of subjects: 0
Study: 26079918

Group type: EXPERIMENTAL
Intervention: Novel 3D stereoscopic viewer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional stereoendoscope
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D high-definition monitors
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3D high-definition monitors
Number of subjects: 40
Study: 24818590

Group type: EXPERIMENTAL
Intervention: Oral Prednisolone in addition to low dose aspirin and heparin
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo in addition to low dose aspirin and heparin
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups (Prednisolone and Placebo)
Number of subjects: 160
Study: 23182016

Group type: EXPERIMENTAL
Intervention: Red-light treatment (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 20
Study: 19684422

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Microperimetry (MP)
Number of subjects: 15
Study: 18316154

Group type: EXPERIMENTAL
Intervention: Inhalation of 20% CO2-enriched air as unconditioned stimulus (US) during acquisition trials.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Conditioned odor cues (CSs) - diluted ammonia and butyric acid.
Number of subjects: 55
Study: 15969861

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study: 12055112

Group type: EXPERIMENTAL
Intervention: 1% escin gel
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: 2% escin gel
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 158
Study: 10472218

Group type: EXPERIMENTAL
Intervention: rapacuronium 1.5 mg kg‐1
Number of subjects: 335

Group type: COMPARATOR
Intervention: succinylcholine 1 mg kg‐1
Number of subjects: 335
Study: 7924784

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 21
Study: 3155316

Group type: EXPERIMENTAL
Intervention: 2.6 mg oral nitroglycerin three times daily for 2 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 6.5 mg oral nitroglycerin three times daily for 2 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 29452684

Group type: EXPERIMENTAL
Intervention: Pimavanserin (two 17 mg tablets daily)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Pimavanserin
Number of subjects: 181
Study: 28194529

Group type: EXPERIMENTAL
Intervention: Supraglottic airway device (SGA)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Endotracheal tube
Number of subjects: 144
Study: 24159051

Group type: EXPERIMENTAL
Intervention: Single-session targeted metacognitive training programme (n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Treatment as usual (n = 14)
Number of subjects: 28
Study: 22694321

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ultrasonic scaler/curette (control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 15
Study: 20039090

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) algorithm-guided antibiotic therapy
Number of subjects: 0
Study: 17905660

Group type: EXPERIMENTAL
Intervention: GnRHa
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: GnRHa plus add-back therapy (progestagen, tibolone, combined oestrogen and progestagen, or raloxifene)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: GnRHa (given for at least 3 months before surgery)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low-dose mifepristone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Asoprisinil
Number of subjects: 29
Study: 15733250

Group type: EXPERIMENTAL
Intervention: Two or more treatment sessions of cognitive-behaviour therapy (CBT)
Number of subjects: 214